Literature DB >> 21888437

Chiral indolo[3,2-f][3]benzazecine-type dopamine receptor antagonists: synthesis and activity of racemic and enantiopure derivatives.

Dina Robaa1, Christoph Enzensperger, Shams Eldin Abulazm, Mohamed M Hefnawy, Hussein I El-Subbagh, Tanveer A Wani, Jochen Lehmann.   

Abstract

Racemic and enantiopure 8-substituted derivatives of the lead dopamine receptor antagonist LE 300 (1) were prepared, and their affinities for the dopamine receptors (D(1)-D(5)) were tested. The separate enantiomers showed significantly different affinities; the (8S)-methyl and (8R)-hyroxymethyl derivatives where the substituents point below the reference plane of the indolo[3,2-f][3]benzazecine scaffold were markedly more active than their enantiomeric counterparts. The racemic 8-carboxy derivative was shown to be selective for the D(5)-receptor, even against D(1).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21888437     DOI: 10.1021/jm200676f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Selective effects of D- and L-govadine in preclinical tests of positive, negative, and cognitive symptoms of schizophrenia.

Authors:  Christopher C Lapish; Kee-Chan Ahn; R Andrew Chambers; Donovan M Ashby; Soyon Ahn; Anthony G Phillips
Journal:  Neuropsychopharmacology       Date:  2014-01-30       Impact factor: 7.853

2.  Evaluation of the Abuse Potential of Novel Amphetamine Derivatives with Modifications on the Amine (NBNA) and Phenyl (EDA, PMEA, 2-APN) Sites.

Authors:  Raly James Perez Custodio; Chrislean Jun Botanas; Seong Shoon Yoon; June Bryan de la Peña; Irene Joy Dela Peña; Mikyung Kim; Taeseon Woo; Joung-Wook Seo; Choon-Gon Jang; Yong Ho Kwon; Nam Yong Kim; Yong Sup Lee; Hee Jin Kim; Jae Hoon Cheong
Journal:  Biomol Ther (Seoul)       Date:  2017-11-01       Impact factor: 4.634

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.